Terms ending in 2026
Every in-force patent on Acclarent, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,399,121 | Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat In force · High confidence | Acclarent, Inc. | In force | High confidence | |
| US 7,559,925 | Methods and Devices for Facilitating Visualization in a Surgical Environment In force · High confidence | Acclarent Inc. | In force | High confidence | |
| US 9,089,258 | Endoscopic Methods and Devices for Transnasal Procedures In force · High confidence | Acclarent Inc., a Delaware Corporation | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.